Home >> Marketplace Directory >> Magnolia launches Mission to Zero

Magnolia launches Mission to Zero

image_pdfCreate PDF

The Steripath Gen2 ISDD product portfolio is an FDA 510(k)-cleared device platform indicated to reduce blood culture contamination. The platform integrates user-controlled negative pressure to divert and sequester the initial 1.5 to 2.0 mL of blood collected for culture.

Magnolia Medical, 888-617-3420

CAP TODAY
X